cryptosporidiosis

cryptosporidiosis
Name	Cryptosporidiosis
Field	Infectious disease
Symptoms	Watery diarrhea, abdominal cramps, nausea, vomiting, fever
Complications	Dehydration, malnutrition, respiratory involvement in immunocompromised
Onset	2–10 days after exposure
Duration	Days to weeks; chronic in immunocompromised
Causes	Protozoan parasites of the genus Cryptosporidium
Risks	HIV/AIDS, organ transplantation, young children, contaminated water
Diagnosis	Stool microscopy, antigen detection, PCR
Treatment	Nitazoxanide; supportive care and antiretroviral therapy
Prevention	Water treatment, hygiene, boiling, filtration

cryptosporidiosis is an intestinal illness caused by protozoan parasites of the genus Cryptosporidium that produces profuse watery diarrhea and systemic complications in vulnerable populations. First recognized in humans in the late 20th century, the disease has been implicated in large waterborne outbreaks and ongoing morbidity among children in low- and middle-income countries. Clinical management ranges from rehydration and nutritional support to targeted antiparasitic therapy and immune restoration in immunosuppressed patients.

Signs and symptoms

Acute presentations typically include watery diarrhea, abdominal cramps, nausea, vomiting and low-grade fever; severe dehydration may follow in infants and older adults. In immunocompetent persons symptoms usually resolve within 1–2 weeks, whereas people with advanced HIV/AIDS, recipients of solid organ transplants or patients on prolonged corticosteroid therapy can develop chronic, profuse diarrhea leading to weight loss, electrolyte imbalance and wasting. Extraintestinal manifestations such as respiratory symptoms have been reported, particularly among individuals with severe immunosuppression or those exposed in nosocomial outbreaks affecting wards in Johns Hopkins Hospital and other tertiary centers. Complications may include hypovolemia, malnutrition, and secondary bacterial infections that occasionally require admission to intensive care units.

Cause and transmission

Cryptosporidiosis is caused primarily by species including Cryptosporidium hominis and Cryptosporidium parvum; zoonotic species such as Cryptosporidium meleagridis and Cryptosporidium canis also infect humans. Transmission commonly occurs via ingestion of oocysts in contaminated water or food, direct fecal-oral contact in daycare settings, and contact with infected animals on farms and at petting zoos implicated in outbreaks linked to venues such as County fairs and agricultural exhibitions. Waterborne epidemics have been documented following contamination of municipal supplies and recreational waters, including notable incidents that prompted investigations by agencies like the Centers for Disease Control and Prevention and regulatory responses from bodies such as the Environmental Protection Agency. International travel to regions with limited water treatment, and exposure during humanitarian crises overseen by organizations like United Nations relief operations, also increases risk.

Pathogenesis and lifecycle

Cryptosporidium spp. are apicomplexan protozoa whose oocysts contain sporozoites that excyst in the small intestine, invade epithelial cells and undergo a complex asexual and sexual reproductive cycle. The parasite localizes to the brush border of enterocytes, forming an intracellular but extracytoplasmic niche that disrupts absorption and induces secretory diarrhea through villous atrophy and crypt hyperplasia. Immune control involves cell-mediated responses, notably CD4+ T lymphocytes and interferon-gamma pathways studied in models at institutions such as National Institutes of Health and research programs at London School of Hygiene & Tropical Medicine. The resilient oocyst stage resists chlorination at concentrations used in municipal disinfection, which explains frequent involvement of treated water supplies and the necessity for filtration and ultraviolet treatment technologies developed by engineering firms and evaluated by standards organizations like American Water Works Association.

Diagnosis

Laboratory confirmation uses microscopic identification of oocysts in stool via modified Ziehl–Neelsen or auramine–rhodamine staining, antigen detection assays, or nucleic acid amplification tests such as PCR performed in clinical laboratories affiliated with hospitals like Mayo Clinic and public health reference centers including the Public Health England laboratories. Multiplex gastrointestinal panels that include Cryptosporidium offer rapid diagnosis in emergency departments and outpatient clinics; electron microscopy and immunofluorescence microscopy are available in specialized centers such as university medical centers at Harvard Medical School and University of California, San Francisco. Diagnostic sensitivity varies with specimen number and concentration techniques, so guidelines from organizations such as the World Health Organization and the Infectious Diseases Society of America recommend multiple stool samples for testing in suspected cases.

Treatment and management

Management emphasizes fluid and electrolyte replacement, nutritional support, and treatment of complications; oral rehydration solutions and, when necessary, intravenous fluids are mainstays in pediatric and severe adult cases treated in facilities like Great Ormond Street Hospital. Nitazoxanide is the only antiparasitic drug approved in many jurisdictions for treatment of immunocompetent patients and is recommended by the World Health Organization for selected cases; efficacy is reduced in advanced immunosuppression, where restoration of immune function via antiretroviral therapy for people with HIV/AIDS is critical. Adjunctive therapies may include antimotility agents under specialist supervision and management of coinfections by teams at tertiary centers such as Cleveland Clinic. In chronic or refractory disease, clinicians consult transplant infectious disease specialists and may consider investigational agents in clinical trials conducted at research institutions like National Institutes of Health clinical centers.

Prevention and control

Preventive strategies combine water safety, hygiene, and public health measures: use of filtration, ultraviolet disinfection and boiling of drinking water, handwashing after animal contact at venues including zoos and petting farms, exclusion policies in daycare settings, and education by public health agencies such as the Centers for Disease Control and Prevention. Outbreak control relies on coordinated responses by municipal utilities, public health laboratories, and regulatory agencies including the Environmental Protection Agency and local health departments; surveillance and reporting to reference centers like European Centre for Disease Prevention and Control facilitate source tracing. Vaccine development remains experimental with research conducted at academic centers such as London School of Hygiene & Tropical Medicine and Johns Hopkins University; preventive measures therefore prioritize water treatment, sanitation infrastructure projects funded by entities like the World Bank, and targeted interventions for high-risk groups guided by policies from organizations like the United Nations Children's Fund.

Category:Parasitic diseases